查找地点
有关时间、上门服务和预约Together, Labcorp and Invitae are harnessing the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes.
Labcorp welcomes the Invitae team, scientific leaders and pioneers in the development and adoption of genetic testing, who have provided over 5 million patients with genetic insights to inform their healthcare.
Mark Schroeder, Executive Vice President and President of Diagnostic Laboratories and Chief Operations Officer of Labcorp
Together, Labcorp and Invitae will support patients, clinicians, and pharma partners across the continuum of care—from therapy development to patient diagnosis, targeted treatments, disease monitoring and precision medicine.
By providing key health insights with improved access to genetic data, Invitae and Labcorp will offer patients knowledge and resources to take control of their health.
With Invitae, Labcorp expands specialty testing, adding industry-leading testing and genetic insights to develop new treatments and deliver personalized care in oncology and select rare diseases.
Together, Invitae and Labcorp will strengthen support for pharma partners from preclinical and clinical research through commercialization with data-driven solutions and insights, accelerating therapeutic drug development.
Providers and patients can sign up for the latest news regarding Invitae and Labcorp. We'll delivered tailored news straight to your inbox.